HAE logo

Haemonetics Corporation (HAE) Cash From Financing

Annual CFF:

$108.82M+$70.66M(+185.18%)
March 29, 2025

Summary

  • As of today, HAE annual cash from financing is $108.82 million, with the most recent change of +$70.66 million (+185.18%) on March 29, 2025.
  • During the last 3 years, HAE annual cash from financing has risen by +$124.57 million (+790.95%).
  • HAE annual cash from financing is now -76.44% below its all-time high of $461.85 million, reached on March 30, 2013.

Performance

HAE Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHAEcash flow metrics

Quarterly CFF:

-$2.44M+$149.01M(+98.39%)
June 28, 2025

Summary

  • As of today, HAE quarterly cash from financing is -$2.44 million, with the most recent change of +$149.01 million (+98.39%) on June 28, 2025.
  • Over the past year, HAE quarterly cash from financing has dropped by -$336.13 million (-100.73%).
  • HAE quarterly cash from financing is now -100.51% below its all-time high of $478.58 million, reached on September 29, 2012.

Performance

HAE Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHAEcash flow metrics

TTM CFF:

-$227.32M-$336.13M(-308.90%)
June 28, 2025

Summary

  • As of today, HAE TTM cash from financing is -$227.32 million, with the most recent change of -$336.13 million (-308.90%) on June 28, 2025.
  • Over the past year, HAE TTM cash from financing has dropped by -$599.76 million (-161.03%).
  • HAE TTM cash from financing is now -144.92% below its all-time high of $506.10 million, reached on September 29, 2012.

Performance

HAE TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHAEcash flow metrics

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

HAE Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+185.2%-100.7%-161.0%
3Y3 Years+791.0%+89.6%-506.0%
5Y5 Years+182.9%-101.6%-556.0%

HAE Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+209.6%-100.7%+98.4%-161.0%at low
5Y5-Year-70.4%+182.9%-100.6%+98.4%-153.4%at low
All-TimeAll-Time-76.4%+182.9%-100.5%+98.4%-144.9%at low

HAE Cash From Financing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$2.44M(+98.4%)
-$227.32M(-308.9%)
Mar 2025
$108.82M(+185.2%)
-$151.45M(>-9900.0%)
$108.82M(-44.7%)
Dec 2024
-
$1.38M(+101.8%)
$196.77M(-35.4%)
Sep 2024
-
-$74.80M(-122.4%)
$304.81M(-18.2%)
Jun 2024
-
$333.69M(+625.5%)
$372.45M(+876.1%)
Mar 2024
$38.16M(+138.4%)
-
-
Mar 2024
-
-$63.50M(-158.0%)
$38.16M(-62.3%)
Dec 2023
-
$109.43M(+1625.8%)
$101.17M(+274.6%)
Sep 2023
-
-$7.17M(-1099.3%)
-$57.94M(+24.2%)
Jun 2023
-
-$598.00K(-23.3%)
-$76.45M(+23.0%)
Mar 2023
-$99.25M(-530.2%)
-$485.00K(+99.0%)
-$99.25M(+7.7%)
Dec 2022
-
-$49.68M(-93.4%)
-$107.53M(-79.6%)
Sep 2022
-
-$25.69M(-9.8%)
-$59.88M(-59.6%)
Jun 2022
-
-$23.39M(-166.9%)
-$37.51M(-138.2%)
Mar 2022
-$15.75M(-104.3%)
-$8.77M(-330.7%)
-$15.75M(-103.7%)
Dec 2021
-
-$2.04M(+38.6%)
$425.77M(+53.2%)
Sep 2021
-
-$3.31M(-102.9%)
$277.87M(+28.1%)
Jun 2021
-
-$1.63M(-100.4%)
$216.87M(-41.0%)
Mar 2021
$367.45M(+380.1%)
$432.76M(+388.6%)
$367.45M(+781.3%)
Dec 2020
-
-$149.94M(-133.1%)
-$53.94M(-208.2%)
Sep 2020
-
-$64.32M(-143.2%)
$49.85M(+2915.8%)
Jun 2020
-
$148.95M(+1209.8%)
$1.65M(+101.3%)
Mar 2020
-$131.21M(-159.2%)
$11.37M(+124.6%)
-$131.21M(+3.2%)
Dec 2019
-
-$46.15M(+59.0%)
-$135.59M(+18.1%)
Sep 2019
-
-$112.52M(-799.3%)
-$165.64M(-211.3%)
Jun 2019
-
$16.09M(+130.0%)
-$53.20M(-5.1%)
Mar 2019
-$50.63M(+58.0%)
$7.00M(+109.2%)
-$50.63M(+70.3%)
Dec 2018
-
-$76.21M(>-9900.0%)
-$170.28M(-98.5%)
Sep 2018
-
-$79.00K(-100.4%)
-$85.76M(+12.9%)
Jun 2018
-
$18.66M(+116.6%)
-$98.43M(+18.4%)
Mar 2018
-$120.64M(-99.7%)
-$112.65M(-1456.3%)
-$120.64M(-554.3%)
Dec 2017
-
$8.31M(+165.2%)
-$18.44M(+74.4%)
Sep 2017
-
-$12.75M(-259.2%)
-$72.13M(-22.3%)
Jun 2017
-
-$3.55M(+66.0%)
-$58.98M(+2.4%)
Mar 2017
-$60.41M(+3.5%)
-$10.45M(+77.0%)
-$60.41M(+7.9%)
Dec 2016
-
-$45.39M(>-9900.0%)
-$65.62M(-182.6%)
Sep 2016
-
$411.00K(+108.2%)
-$23.22M(+38.6%)
Jun 2016
-
-$4.99M(+68.1%)
-$37.84M(+39.6%)
Mar 2016
-$62.62M(-88.9%)
-$15.65M(-423.5%)
-$62.62M(-40.9%)
Dec 2015
-
-$2.99M(+79.0%)
-$44.45M(-6.6%)
Sep 2015
-
-$14.21M(+52.3%)
-$41.69M(-22.2%)
Jun 2015
-
-$29.77M(-1282.4%)
-$34.12M(-2.9%)
Mar 2015
-$33.16M(-60.2%)
$2.52M(+1234.2%)
-$33.16M(+20.5%)
Dec 2014
-
-$222.00K(+96.7%)
-$41.71M(+20.2%)
Sep 2014
-
-$6.64M(+76.9%)
-$52.29M(+11.4%)
Jun 2014
-
-$28.81M(-377.6%)
-$59.02M(-185.1%)
Mar 2014
-$20.70M(-104.5%)
-$6.03M(+44.1%)
-$20.70M(+52.8%)
Dec 2013
-
-$10.80M(+19.2%)
-$43.85M(-19.1%)
Sep 2013
-
-$13.37M(-240.7%)
-$36.83M(-108.1%)
Jun 2013
-
$9.50M(+132.6%)
$455.13M(-1.5%)
Mar 2013
$461.85M(+1615.8%)
-$29.18M(-673.3%)
$461.85M(-6.9%)
Dec 2012
-
-$3.77M(-100.8%)
$496.28M(-1.9%)
Sep 2012
-
$478.58M(+2849.3%)
$506.10M(+2804.9%)
Jun 2012
-
$16.23M(+209.4%)
-$18.71M(+38.6%)
Mar 2012
-$30.47M(-68.5%)
$5.24M(-13.2%)
-$30.47M(+3.7%)
Dec 2011
-
$6.04M(+113.1%)
-$31.63M(-152.3%)
Sep 2011
-
-$46.22M(-1134.7%)
-$12.54M(-130.3%)
Jun 2011
-
$4.47M(+9.3%)
$41.32M(+328.5%)
Mar 2011
-$18.08M(-29.4%)
$4.09M(-83.7%)
-$18.08M(-4.3%)
Dec 2010
-
$25.13M(+229.1%)
-$17.34M(+76.3%)
Sep 2010
-
$7.64M(+113.9%)
-$73.18M(+16.6%)
Jun 2010
-
-$54.94M(-1236.7%)
-$87.75M(-528.1%)
Mar 2010
-$13.97M(+54.5%)
$4.83M(+115.7%)
-$13.97M(+10.8%)
Dec 2009
-
-$30.71M(-342.7%)
-$15.66M(-204.4%)
Sep 2009
-
-$6.94M(-136.8%)
$14.99M(+483.0%)
Jun 2009
-
$18.84M(+499.6%)
$2.57M(+108.4%)
Mar 2009
-$30.74M
$3.14M(+5814.5%)
-$30.74M(+8.8%)
Dec 2008
-
-$55.00K(+99.7%)
-$33.69M(+12.4%)
Sep 2008
-
-$19.36M(-33.8%)
-$38.47M(+44.4%)
DateAnnualQuarterlyTTM
Jun 2008
-
-$14.46M(-7673.3%)
-$69.22M(+5.5%)
Mar 2008
-$73.23M(-106.0%)
$191.00K(+104.0%)
-$73.23M(-0.8%)
Dec 2007
-
-$4.83M(+90.4%)
-$72.64M(+27.3%)
Sep 2007
-
-$50.11M(-171.2%)
-$99.98M(-83.4%)
Jun 2007
-
-$18.48M(-2483.9%)
-$54.51M(-53.3%)
Mar 2007
-$35.55M(-394.0%)
$775.00K(+102.4%)
-$35.55M(-16.1%)
Dec 2006
-
-$32.16M(-593.2%)
-$30.61M(-1469.1%)
Sep 2006
-
-$4.64M(-1074.8%)
-$1.95M(-125.5%)
Jun 2006
-
$476.00K(-91.7%)
$7.64M(-36.8%)
Mar 2006
$12.09M(-16.8%)
$5.72M(+263.2%)
$12.09M(+5.3%)
Dec 2005
-
-$3.50M(-170.7%)
$11.48M(-43.8%)
Sep 2005
-
$4.95M(+0.5%)
$20.42M(+17.1%)
Jun 2005
-
$4.93M(-3.5%)
$17.44M(+20.0%)
Mar 2005
$14.53M(+1923.8%)
$5.11M(-6.0%)
$14.53M(+284.3%)
Dec 2004
-
$5.43M(+175.6%)
$3.78M(-27.2%)
Sep 2004
-
$1.97M(-2.5%)
$5.19M(+67.8%)
Jun 2004
-
$2.02M(+135.8%)
$3.09M(+330.9%)
Mar 2004
$718.00K(+101.5%)
-$5.64M(-182.5%)
$718.00K(+117.7%)
Dec 2003
-
$6.84M(+5489.0%)
-$4.05M(+75.1%)
Sep 2003
-
-$127.00K(+64.2%)
-$16.28M(+34.0%)
Jun 2003
-
-$355.00K(+96.6%)
-$24.65M(+49.7%)
Mar 2003
-$49.00M(-424.9%)
-$10.41M(-93.4%)
-$49.00M(+30.6%)
Dec 2002
-
-$5.38M(+36.7%)
-$70.58M(-9.8%)
Sep 2002
-
-$8.50M(+65.6%)
-$64.28M(-39.9%)
Jun 2002
-
-$24.70M(+22.8%)
-$45.94M(-392.1%)
Mar 2002
-$9.34M(-286.4%)
-$31.99M(-3604.1%)
-$9.34M(-129.4%)
Dec 2001
-
$913.00K(-90.7%)
$31.72M(-28.2%)
Sep 2001
-
$9.84M(-17.3%)
$44.20M(+53.5%)
Jun 2001
-
$11.90M(+31.3%)
$28.80M(+475.0%)
Mar 2001
$5.01M(+128.2%)
$9.06M(-32.3%)
$5.01M(+143.7%)
Dec 2000
-
$13.39M(+341.0%)
-$11.46M(+34.4%)
Sep 2000
-
-$5.56M(+53.3%)
-$17.48M(+23.2%)
Jun 2000
-
-$11.89M(-60.5%)
-$22.76M(-27.9%)
Mar 2000
-$17.79M(-223.1%)
-$7.41M(-200.6%)
-$17.79M(-11.9%)
Dec 1999
-
$7.37M(+168.0%)
-$15.90M(+12.2%)
Sep 1999
-
-$10.83M(-56.6%)
-$18.11M(-243.3%)
Jun 1999
-
-$6.92M(-25.4%)
-$5.28M(+4.2%)
Mar 1999
-$5.50M(-113.7%)
-$5.52M(-207.0%)
-$5.50M(-778.8%)
Dec 1998
-
$5.15M(+157.0%)
$811.00K(+114.1%)
Sep 1998
-
$2.00M(+128.1%)
-$5.74M(-144.7%)
Jun 1998
-
-$7.15M(-993.4%)
$12.85M(-67.9%)
Mar 1998
$40.11M(+1354.9%)
$800.00K(+157.1%)
$40.10M(+9.0%)
Dec 1997
-
-$1.40M(-106.8%)
$36.80M(+1.4%)
Sep 1997
-
$20.60M(+2.5%)
$36.30M(+87.1%)
Jun 1997
-
$20.10M(+904.0%)
$19.40M(+592.9%)
Mar 1997
$2.76M(+114.5%)
-$2.50M(-31.6%)
$2.80M(-3.4%)
Dec 1996
-
-$1.90M(-151.4%)
$2.90M(+149.2%)
Sep 1996
-
$3.70M(+5.7%)
-$5.90M(+51.6%)
Jun 1996
-
$3.50M(+245.8%)
-$12.20M(+35.8%)
Mar 1996
-$18.99M(-960.0%)
-$2.40M(+77.6%)
-$19.00M(+1.6%)
Dec 1995
-
-$10.70M(-311.5%)
-$19.30M(-221.7%)
Sep 1995
-
-$2.60M(+21.2%)
-$6.00M(-700.0%)
Jun 1995
-
-$3.30M(-22.2%)
$1.00M(-54.5%)
Mar 1995
$2.21M(+19.7%)
-$2.70M(-203.8%)
$2.20M(-66.2%)
Dec 1994
-
$2.60M(-40.9%)
$6.50M(+1200.0%)
Sep 1994
-
$4.40M(+309.5%)
$500.00K(>+9900.0%)
Jun 1994
-
-$2.10M(-231.3%)
$0.00(-100.0%)
Mar 1994
$1.84M(+117.2%)
$1.60M(+147.1%)
$1.80M(+700.0%)
Dec 1993
-
-$3.40M(-187.2%)
-$300.00K(>-9900.0%)
Sep 1993
-
$3.90M(+1400.0%)
$0.00(+100.0%)
Jun 1993
-
-$300.00K(+40.0%)
-$10.30M(+4.6%)
Mar 1993
-$10.76M(-1509.7%)
-$500.00K(+83.9%)
-$10.80M(+18.8%)
Dec 1992
-
-$3.10M(+51.6%)
-$13.30M(-160.8%)
Sep 1992
-
-$6.40M(-700.0%)
-$5.10M(-304.0%)
Jun 1992
-
-$800.00K(+73.3%)
$2.50M(+212.5%)
Mar 1992
$763.00K(+106.6%)
-$3.00M(-158.8%)
$800.00K(-78.9%)
Dec 1991
-
$5.10M(+325.0%)
$3.80M(+392.3%)
Sep 1991
-
$1.20M(+148.0%)
-$1.30M(+48.0%)
Jun 1991
-
-$2.50M
-$2.50M
Mar 1991
-$11.51M
-
-

FAQ

  • What is Haemonetics Corporation annual cash from financing?
  • What is the all-time high annual cash from financing for Haemonetics Corporation?
  • What is Haemonetics Corporation annual cash from financing year-on-year change?
  • What is Haemonetics Corporation quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for Haemonetics Corporation?
  • What is Haemonetics Corporation quarterly cash from financing year-on-year change?
  • What is Haemonetics Corporation TTM cash from financing?
  • What is the all-time high TTM cash from financing for Haemonetics Corporation?
  • What is Haemonetics Corporation TTM cash from financing year-on-year change?

What is Haemonetics Corporation annual cash from financing?

The current annual cash from financing of HAE is $108.82M

What is the all-time high annual cash from financing for Haemonetics Corporation?

Haemonetics Corporation all-time high annual cash from financing is $461.85M

What is Haemonetics Corporation annual cash from financing year-on-year change?

Over the past year, HAE annual cash from financing has changed by +$70.66M (+185.18%)

What is Haemonetics Corporation quarterly cash from financing?

The current quarterly cash from financing of HAE is -$2.44M

What is the all-time high quarterly cash from financing for Haemonetics Corporation?

Haemonetics Corporation all-time high quarterly cash from financing is $478.58M

What is Haemonetics Corporation quarterly cash from financing year-on-year change?

Over the past year, HAE quarterly cash from financing has changed by -$336.13M (-100.73%)

What is Haemonetics Corporation TTM cash from financing?

The current TTM cash from financing of HAE is -$227.32M

What is the all-time high TTM cash from financing for Haemonetics Corporation?

Haemonetics Corporation all-time high TTM cash from financing is $506.10M

What is Haemonetics Corporation TTM cash from financing year-on-year change?

Over the past year, HAE TTM cash from financing has changed by -$599.76M (-161.03%)
On this page